FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: PeakClear all
BRONCHITOL
mannitol
Peak
INHALATION · POWDER
2020
NDA
30/100
CABAZITAXEL
cabazitaxel
Peak
Accord Biopharma
INTRAVENOUS · SOLUTION
combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimenprostate cancer
2021
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2013
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2017
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2021
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
Carbon Biosciences
INHALATION · GAS
2022
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2020
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2013
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2013
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2013
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2022
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2019
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
Carbon Biosciences
INHALATION · GAS
2013
NDA
30/100
CARBON DIOXIDE, USP
carbon dioxide
Peak
INHALATION · GAS
2014
NDA
30/100
CARMUSTINE
carmustine
Peak
Accord Biopharma
INTRAVENOUS · POWDER
glioblastomamyeloma+1
2022
NDA
30/100
CASSIPA
buprenorphine hydrochloride; naloxone hydrochloride
Peak
Teva
SUBLINGUAL · FILM
2018
NDA
30/100
CEFAZOLIN IN DEXTROSE
cefazolin sodium
Peak
Baxter
INTRAVENOUS · SOLUTION
respiratory tract infections due to Streptococcus pneumoniaeStaphylococcus aureus+15
2015
NDA
30/100
CEFAZOLIN SODIUM
cefazolin
Peak
Hikma
INTRAVENOUS · POWDER
respiratory tract infections due to Streptococcus pneumoniaeKlebsiella species+24
2022
NDA
30/100
CEFTAZIDIME IN DEXTROSE CONTAINER
ceftazidime
Peak
B. Braun
INJECTION · INJECTABLE
the following infections caused by designated susceptible Gram-negative microorganisms in adultused in combination with metronidazole ( ) Complicated Urinary Tract Infections (cUTI)+20
2011
NDA
30/100
CERIANNA
fluoroestradiol f 18
Peak
INTRAVENOUS · SOLUTION
breast cancer
2020
NDA
30/100
CHOLBAM
cholic acid
Peak
Mirum Pharmaceuticals
ORAL · CAPSULE
bile acid synthesis disorders due to single enzyme defects (SEDs) 1
2015
NDA
30/100
CHOLINE C-11
choline c-11
Peak
INTRAVENOUS · INJECTABLE
prostate cancer
2012
NDA
30/100
CIMDUO
lamivudine and tenofovir disoproxil fumarate
Peak
Viatris (2)
ORAL · TABLET
combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult
2018
NDA
30/100
CITALOPRAM HYDROBROMIDE
citalopram
Peak
Almatica Pharma
ORAL · CAPSULE
Major Depressive Disorder (MDD) in adults
2022
NDA
30/100